Cardiac drugs and outcome in COVID-19
- 14 April 2020
- journal article
- letter
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 113 (7), 523-524
- https://doi.org/10.1093/qjmed/hcaa127
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Patterns of heart injury in COVID‐19 and relation to outcomeJournal of Medical Virology, 2020
- Reporting of all cardiac medications and their outcome in COVID‐19Journal of Medical Virology, 2020
- COVID-19 and Cardiovascular DiseaseCirculation, 2020
- COVID-19 and the cardiovascular systemNature Reviews Cardiology, 2020
- Are certain drugs associated with enhanced mortality in COVID-19?QJM: An International Journal of Medicine, 2020
- Coronavirus disease-2019: An update on third coronavirus outbreak of 21st centuryQJM: An International Journal of Medicine, 2020
- Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populationsCell Discovery, 2020
- Angiotensin-Converting Enzyme 2: The First DecadeInternational Journal of Hypertension, 2011